½ÃÀ庸°í¼­
»óǰÄÚµå
1587657

¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå ¿¹Ãø : Á¦Ç°º°, Àα¸ Åë°èº°, ¼ººÐº°, À¯Åë °æ·Îº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº° ºÐ¼®(-2030³â)

Mesotherapy Market Forecasts to 2030 - Global Analysis By Product (Injectables, Devices and Other Products), Demographic, Ingredient, Distribution Channel, Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀåÀº 2024³â 7¾ï 6,648¸¸ ´Þ·¯·Î ÃßÁ¤µÇ°í, 2030³â¿¡´Â 11¾ï 6,324¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È CAGR 7.2%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¸ÞÁ¶Å×¶óÇÇ´Â ¼Ò·®ÀÇ ºñŸ¹Î, È¿¼Ò, È£¸£¸ó, ½Ä¹° ÃßÃâ¹°À» ÇǺÎÀÇ Á߹迱Ãþ¿¡ ÁÖÀÔÇÏ´Â Àúħ½À ¹Ì¿ë¹ýÀÔ´Ï´Ù. ±× ¸ñÀûÀº ÇǺÎÀÇ È¸Ãá°ú ź·Â, Å»¸ð Ä¡·á, Áö¹æ °¨¼Ò, ¼¿·ê¶óÀÌÆ® °³¼±ÀÔ´Ï´Ù. ¸Þ¼ÒÅ×¶óÇǴ ƯÁ¤ ºÎÀ§¿¡ ¿µ¾çºÐÀ» Àü´ÞÇÏ¿© Ç÷¾× ¼øÈ¯°ú Äݶó°Õ »ý¼ºÀ» ÃËÁøÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î ¾ÈƼ¿¡ÀÌ¡, ½Åü À±°û Çü¼º, ÇǺΠȸÃá µî¿¡ »ç¿ëµÇ¸ç Áö¹æÈíÀÔ°ú °°Àº ħ½ÀÀûÀÎ ¼ºÇü¼ö¼úÀ» ´ëüÇÒ ¼ö ÀÖ´Â ºñ¿Ü°úÀû ¼±ÅÃÁö¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù.

ºñħ½ÀÀû ¹Ì¿ë½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

ÇǺΠȸÃá, Áö¹æ °¨¼Ò, ¸ð¹ß Àç»ý µî ´Ù¿îŸÀÓÀ» ÃÖ¼ÒÈ­ÇÑ ºñħ½ÀÀûÀÎ ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¼ö¼ú¿¡ µû¸¥ À§ÇèÀ̳ª ȸº¹ÀÌ ÇÊ¿ä¾ø´Â ½Å¼ÓÇÑ °á°ú¸¦ ¿ä±¸ÇÏ´Â ¼ÒºñÀÚ¸¦ ¸Å·ÂÀûÀÔ´Ï´Ù. ¾ÈƼ ¿¡ÀÌ¡°ú ¹Ì¿ë ¼ºÇü¿¡ À־ º¸´Ù ħ½À¼ºÀÌ ³·Àº ¼±ÅÃÀÌ ¼±È£µÇ°í ÀÖ¾î ÀÌ·¯ÇÑ ¿ì·Á¿¡ È¿°úÀûÀ¸·Î ´ëóÇÒ ¼ö ÀÖ´Â ¸ÞÁ¶Å×¶óÇÇÀÇ ´É·ÂÀº ƯÈ÷ ÀÚ¿¬ÀûÀÎ °³¼±À̳ª ¿Ï¸¸ÇÑ ¿ÜÇüÀÇ °³¼±À» ¿ä±¸ÇÏ´Â »ç¶÷µé »çÀÌ¿¡¼­ ±× ä¿ëÀ» µÞ¹ÞÄ§ÇØ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÕ´Ï´Ù.

Ç¥ÁØÈ­ ºÎÁ·

¸ÞÁ¶Å×¶óÇÇÀÇ Ç¥ÁØÈ­ ºÎÁ·Àº Ä¡·á ±â¼ú, Á¦Çü ¹× °á°ú¿¡ Àϰü¼ºÀÌ ¾øÀ¸¸ç ½ÃÀåÀ» ¹æÇØÇÕ´Ï´Ù. ½Ã¼úÀÚ°¡ »ç¿ëÇÏ´Â ºñŸ¹Î, È¿¼Ò ¹× ±âŸ ¹°ÁúÀÇ ³óµµ°¡ ´Ù¸¦ ¼ö ÀÖÀ¸¸ç ¿¹±âÄ¡ ¾ÊÀº °á°ú¿Í ȯÀÚÀÇ ºÒ¸¸À» ÃÊ·¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àϰü¼ºÀÌ ¾ø´Â °ÍÀº ¾ÈÀü°ú È¿´É¿¡ ´ëÇÑ ¿ì·Á¸¦ °®°Ô ÇÏ°í ½Ã¼ú¿¡ ´ëÇÑ ½Å·Ú¸¦ È®¸³ÇÏ´Â °ÍÀ» ¾î·Æ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ Ç¥ÁØÈ­µÈ ÇÁ·ÎÅäÄÝÀÌ ¾øÀ¸¸é ±ÔÁ¦±â°üÀÇ ½ÂÀΰú °¨µ¶µµ ¾î·Á¿öÁö¸ç ÀϺΠÁö¿ª¿¡¼­´Â ¼ö¿ëÀÌ Á¦ÇÑµÇ¾î ½ÃÀå ÀüüÀÇ ¼ºÀåÀÌ µÐÈ­µË´Ï´Ù.

³²¼º ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡

³²¼ºÀÇ ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ³ëÈ­, Å»¸ð, ½Åü À±°û µîÀÇ ¿ì·Á¿¡ ´ëóÇÏ°í ¿Ü¸ð¸¦ Çâ»ó½Ã۱â À§ÇØ ºñħ½ÀÀûÀÎ ¹Ì¿ë ½Ã¼úÀ» ¿ä±¸ÇÏ´Â °ÍÀÔ´Ï´Ù. ¸ÞÁ¶Å×¶óÇÇÀÇ Àúħ½À¼º°ú ÁÖ¸§, Áö¹æ°¨¼Ò, ¹Ú¸ð µîÀÇ ¹®Á¦¸¦ Ä¡·áÇÏ´Â ´É·ÂÀº ¼¶¼¼Çϸ鼭µµ È¿°úÀûÀÎ Ä¡·á¸¦ ¿ä±¸ÇÏ´Â ³²¼ºÀÇ ±âÈ£¿¡ ¸Â½À´Ï´Ù. ÀÌ·¯ÇÑ ³²¼º Àα¸ Áõ°¡´Â ¹Ì¿ë Ŭ¸®´Ð¿¡ »õ·Î¿î ¼öÀÍ¿øÀ» °¡Á®¿À°í, ½ÃÀåÀ» È®´ëÇϰí, °³º°È­µÈ ¼ºº°À» ´ë»óÀ¸·Î ÇÏ´Â ¸ÞÁ¶Å×¶óÇÇ ¼Ö·ç¼Ç ¼ö¿ä¸¦ ºÎÃß±é´Ï´Ù.

ºÎÁ¤ÀûÀÎ ÀϹÝÀνİú ¾ÈÀü¿¡ ´ëÇÑ ¿ì·Á

°¨¿°, Ÿ¹Ú»ó, ¾Ë·¹¸£±â ¹ÝÀÀ°ú °°Àº ºÎÀÛ¿ëÀÇ ¹ß»ýÀº ¸ÞÁ¶Å×¶óÇÇÀÇ ¾ÈÀü¼º°ú È¿´É¿¡ ÀǽÉÀ» ǰ°Ô ÇÕ´Ï´Ù. °Ô´Ù°¡ Ç¥ÁØÈ­µÈ Ä¡·á¹ýÀÌ ¾ø°í Ŭ¸®´Ð¿¡ µû¶ó Á¦ÇüÀÌ ´Ù¸£±â ¶§¹®¿¡ °á°ú¿¡ Àϰü¼ºÀÌ ¾øÀ¸¸ç ÀáÀç °í°´À» ´õ¿í ¸Ö¾îÁö°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯ÇØÇÑ °á°ú¿Í ºÒÃæºÐÇÑ ÈÆ·ÃÀ» ¹ÞÀº ½Ã¼úÀÚ°¡ Ä¡·á¸¦ Çϰí ÀÖ´Ù°í ÇÏ´Â ¹Ìµð¾îÀÇ º¸µµ´Â ¼ÒºñÀÚ¿¡°Ô ¸ÞÁ¶Å×¶óÇǸ¦ ¹Þ´Â °ÍÀ» ÁÖÀúÇÏ°Ô ÇÏ°í ½ÃÀåÀÇ ¼ºÀåÀ» µÐÇÏ°Ô ¸¸µå´Â ºÎÁ¤ÀûÀÎ À̹ÌÁö¸¦ Á¶ÀåÇϰí ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ À¯ÇàÀº ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. óÀ½¿¡´Â ¸ÞÁ¶Å×¶óÇÇ¿Í °°Àº ¼±ÅÃÀû ¹Ì¿ë ½Ã¼úÀº Æó¼â, Ŭ¸®´Ð Æó¼â, »çȸÀû °Å¸®¸¦ µÎ´Â Á¶Ä¡·Î °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª ±ÔÁ¦°¡ ¿ÏÈ­µÇ°í ¿ø°ÝÀÇ·á¿¡ ÀÇÇÑ ÁøÂûÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ºñħ½ÀÀûÀÎ ¹Ì¿ëÄ¡·á¿¡ ´ëÇÑ ¼ö¿ä´Â ȸº¹µÇ°í °¡»óȸÀÇ Áß¿¡ »ç¶÷µéÀÌ ÀÚ½ÅÀÇ ¿Ü¸ð¸¦ º¸´Ù ÀǽÄÇÏ°Ô µÈ 'ÁÜ È¿°ú'°¡ µÞ¹ÞÄ§ÇØ ÁÖ¾ú½À´Ï´Ù. °Ô´Ù°¡ ÆÒµ¥¹Í¿¡ µû¸¥ ¼¿ÇÁÄÉ¾î µ¿Çâ Áõ°¡¿Í À£´Ï½º¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ °ü½É Áõ°¡°¡ ½ÃÀåÀÇ È¸º¹À» ´õ¿í µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ¾Æ¹Ì³ë»ê ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á

¿¹Ãø ±â°£ µ¿¾È ƯÈ÷ ÇǺΠȸÃá°ú ¾ÈƼ ¿¡ÀÌ¡ µîÀÇ Ä¡·á È¿°ú°¡ ³ô¾ÆÁö±â ¶§¹®¿¡ ¾Æ¹Ì³ë»ê ºÎ¹®ÀÌ ÃÖ´ë ½ÃÀå Á¡À¯À²À» ȹµæÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¾Æ¹Ì³ë»êÀº Äݶó°Õ°ú ¿¤¶ó½ºÆ¾ÀÇ »ý»êÀ» ÀÚ±ØÇϰí ÇǺÎÀÇ Åº·Â¼º°ú Áú°¨À» Çâ»ó½Ã۱â À§ÇØ ¸ÞÁ¶Å×¶óÇÇ Á¦Á¦¿¡ ÇʼöÀûÀÎ ¼ººÐÀÔ´Ï´Ù. ¼¼Æ÷ ¼öº¹ ¹× Àç»ý¿¡ °ü¿©Çϱ⠶§¹®¿¡ ÁÖ¸§, ÀÛÀº ÁÖ¸§, ÇǺΠóÁüÀ» Ä¡·áÇÏ´Â Áß¿äÇÑ ¼ººÐÀÔ´Ï´Ù. ºñħ½ÀÀûÀ̰í È¿°úÀûÀÎ ¹Ì¿ë ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö´Â °¡¿îµ¥, ¾Æ¹Ì³ë»ê ±â¹ÝÀÇ ¸ÞÁ¶Å×¶óÇÇ Ä¡·á°¡ Àα⸦ ²ø°í ÀÖÀ¸¸ç, ¼ÒºñÀÚ°¡ ÇǺÎÀÇ °Ç°­°ú Ȱ·Â Çâ»óÀ» ¿ä±¸ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È º´¿ø ºÎ¹®ÀÇ CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È Àü¹® ÀÎÇÁ¶ó, ¼÷·ÃµÈ ÀÇ·á Á¾»çÀÚ, Á¾ÇÕÀûÀÎ Ä¡·á·Î º´¿ø ºÎ¹®ÀÌ °¡Àå ³ôÀº ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º´¿øÀº ¹Ì¿ë Ä¡·á¿¡¼­ ½Å·ÚÇÒ ¼ö ÀÖ´Â ±â°üÀ̸ç, ÇǺΠȸÃá, ¾ÈƼ¿¡ÀÌ¡, Áö¹æ °¨¼Ò¸¦ À§ÇÑ ¸ÞÁ¶Å×¶óÇÇ¿Í °°Àº Àü¹®ÀûÀÌ°í ºñħ½ÀÀûÀÎ ½Ã¼úÀ» ¿ä±¸Çϴ ȯÀÚ¿¡°Ô ¸Å·ÂÀûÀÔ´Ï´Ù. ÷´Ü ±â¼ú°ú ±ÔÁ¦µÈ ȯ°æÀ» ÀÌ¿ëÇÒ ¼ö ÀÖ´Â º´¿øÀº º¸´Ù ³ôÀº ¾ÈÀü¼º°ú È¿´ÉÀ» º¸ÀåÇϰí ȯÀÚÀÇ ½Å·Ú¸¦ ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ º´¿ø°ú ¹Ì¿ë ¼­ºñ½º Á¦°ø¾÷ü °£ÀÇ ÆÄÆ®³Ê½Ê È®´ë´Â ¸ÞÁ¶Å×¶óÇÇ Ã¤¿ë È®´ë¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, º¸´Ù ±¤¹üÀ§ÇÑ È¯ÀÚ ±â¹ÝÀ» ÅëÇØ ½ÃÀå ¼ºÀåÀ» À̲ø°í ÀÖ½À´Ï´Ù.

°¡Àå Á¡À¯À²ÀÌ ³ôÀº Áö¿ª

°¡Ã³ºÐ ¼Òµæ Áõ°¡, ¹Ì¿ë ½Ã¼ú¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, °í·ÉÈ­ »çȸÀÇ ¹ßÀüÀ¸·Î ¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Çѱ¹, ÀϺ», Àεµ µîÀÇ ±¹°¡µéÀÌ ºñħ½ÀÀûÀÎ ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä¸¦ ¼±µµÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â ¸ÞÁ¶Å×¶óÇÇÀÇ ±â¼ú°ú Á¦Ç°ÀÇ Áøº¸¿¡ ´õÇØ, ¹Ì¿ë ½Ã¼úÀ» ¸ñÀûÀ¸·Î ÇÏ´Â ÀÇ·á Åõ¾î¸®ÁòÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ÒºñÀÚµé »çÀÌ¿¡¼­ ¼¿ÇÁ Äɾî¿Í À£´Ï½º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ÀÌ Áö¿ª¿¡¼­ ¸ÞÁ¶Å×¶óÇÇ ¼Ö·ç¼Ç ¼ö¿ä¸¦ ´õ¿í ¹Ð¾î ¿Ã¸®°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì´Â °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̰ÍÀº ºñħ½ÀÀûÀÎ ¹Ì¿ë Ä¡·á¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡¿Í ÇǺΠȸÃá Ä¡·á¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡·Î ÀÎÇÑ °ÍÀÔ´Ï´Ù. ÀÌ Áö¿ªÀÇ ³ëÀÎ Àα¸´Â ¾ÈƼ ¿¡ÀÌ¡, Áö¹æ °¨¼Ò ¹× ÇǺΠ±äÃàÀ» À§ÇÑ È¿°úÀûÀÎ ¼Ö·ç¼ÇÀ» ã°í ÀÖ½À´Ï´Ù. °Ô´Ù°¡ ±â¼úÀÇ Áøº¸¿Í Çõ½ÅÀûÀÎ ¹èÇÕÀº Ä¡·áÀÇ È¿´É°ú ¾ÈÀü¼ºÀ» Çâ»ó½ÃŰ°í ´õ ¸¹Àº °í°´À» ²ø¾îµéÀ̰í ÀÖ½À´Ï´Ù. ¼÷·ÃµÈ ½Ã¼úÀÚ¿Í ¹Ì¿ë Ŭ¸®´ÐÀÇ °ß°íÇÑ ³×Æ®¿öÅ©°¡ ½ÃÀå È®´ë¸¦ ´õ¿í µÞ¹ÞħÇÏ´Â ÇÑÆí, ¼Ò¼È ¹Ìµð¾îÀÇ ¿µÇâ·ÂÀÌ ´Ù¾çÇÑ ÃþÀÇ ¹Ì¿ë °­È­¿¡ ´ëÇÑ °ü½ÉÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ÁøÃâ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå ÃßÁ¤, ¿¹Ãø ¹× CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞº° ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç Á¤º¸¿ø
    • 1Â÷ Á¶»ç Á¤º¸¿ø
    • 2Â÷ Á¶»ç Á¤º¸¿ø
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼­¹®
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô ÁøÀÔ¾÷ÀÚÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå : Á¦Ç°º°

  • ¼­¹®
  • ÁÖ»çÁ¦
    • ¸ÞÁ¶Å×¶óÇÇ ÁÖ»çÁ¦
    • ¹Ù´ÃÀ» »ç¿ëÇÏÁö ¾Ê´Â ÁÖ»çÁ¦
  • µð¹ÙÀ̽º
    • ¸ÞÁ¶Å×¶óÇǰÇ
    • Àü±âõ°øÀåÄ¡
    • ±âŸ ÁÖÀÔ ½Ã½ºÅÛ
  • ±âŸ

Á¦6Àå ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå : Àα¸ Åë°èº°

  • ¼­¹®
  • ¿¬·ÉÃþ
    • ¼ºÀÎ(18-35¼¼)
    • Áß³â(36-55¼¼)
    • °í·ÉÀÚ(56¼¼ ÀÌ»ó)
  • ¼ºº°
    • ³²¼º
    • ¿©¼º
  • ±âŸ Àα¸Åë°è

Á¦7Àå ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå : ÄÄÆ÷³ÍÆ®º°

  • ¼­¹®
  • µ¿Á¾ ¿ä¹ý Ä¡·á
  • ºñŸ¹Î°ú ¹Ì³×¶ö
  • È÷¾Ë·ç·Ð»ê
  • ¾Æ¹Ì³ë»ê
  • ½Ä¹° ÃßÃâ¹°
  • ±âŸ ¼ººÐ

Á¦8Àå ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå : À¯Åë ä³Îº°

  • ¼­¹®
  • Á÷Á¢ ÆÇ¸Å
  • ¿Â¶óÀÎ ÆÇ¸Å
  • ¾à±¹
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦9Àå ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå : ¿ëµµº°

  • ¼­¹®
  • ¾ÈƼ ¿¡ÀÌ¡
  • ¾ó±¼ÀÇ È¸Ãá
  • ½ºÆ®·¹Ä¡ ¸¶Å©
  • ¿©µå¸§ ¹× ÈäÅÍÀÇ Ä¡·á
  • Áö¹æ °¨¼Ò
  • Å»¸ð
  • ±âŸ

Á¦10Àå ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼­¹®
  • º´¿ø
  • ÇǺΰú ¹× ¹Ì¿ë Ŭ¸®´Ð
  • ±âŸ

Á¦11Àå ¼¼°èÀÇ ¸ÞÁ¶Å×¶óÇÇ ½ÃÀå : Áö¿ªº°

  • ¼­¹®
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦12Àå ÁÖ¿ä °³¹ß

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷ ¹× ÇÕÀÛÅõÀÚ(JV)
  • Àμö ¹× ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦13Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Mesoestetic Pharmaceutical
  • Revitalash Cosmetics, Inc.
  • MediK8
  • Filorga Laboratoires
  • Dusa Pharmaceuticals, Inc.
  • Hyaluronic Acid USA
  • Suneva Medical, Inc.
  • MesoRex
  • Revive Light Therapy
  • Dr. RFR Group
  • Mesotech
  • VIVACY Laboratoires
  • Intraline
  • Suneva Medical
  • Allergan(AbbVie Inc.)
  • Merz Pharmaceuticals
  • Galderma
  • Croma Pharma GmbH
  • Aesthetic Solutions
  • Hugel, Inc.
AJY 24.11.22

According to Stratistics MRC, the Global Mesotherapy Market is accounted for $766.48 million in 2024 and is expected to reach $1163.24 million by 2030 growing at a CAGR of 7.2% during the forecast period. Mesotherapy is a minimally invasive cosmetic procedure that involves injecting small amounts of vitamins, enzymes, hormones, and plant extracts into the skin's mesoderm layer. It aims to rejuvenate and tighten skin, treat hair loss, reduce fat, and improve cellulite. Mesotherapy delivers nutrients to specific areas, stimulating circulation and collagen production. Commonly used for anti-aging, body contouring, and skin rejuvenation, it offers a non-surgical alternative to more invasive cosmetic procedures like liposuction.

Market Dynamics:

Driver:

Increasing demand for non-invasive aesthetic procedures

The growing demand for non-invasive aesthetic procedures such as skin rejuvenation, fat reduction, and hair restoration with minimal downtime, attracting consumers who seek quick results without the risks and recovery associated with surgery. As individuals increasingly prefer less invasive options for anti-aging and cosmetic improvements, mesotherapy's ability to address these concerns effectively boosts its adoption, particularly among people seeking natural enhancements and gradual improvements in appearance, thereby fostering the growth of the market.

Restraint:

Lack of standardization

Lack of standardization in mesotherapy hinders the market by creating inconsistencies in treatment techniques, formulations, and results. Different practitioners may use varying concentrations of vitamins, enzymes, or other substances, leading to unpredictable outcomes and patient dissatisfaction. This inconsistency raises concerns about safety and efficacy, making it harder to establish trust in the procedure. Additionally, without standardized protocols, it becomes difficult for regulatory bodies to approve or oversee the practice, limiting its acceptance in some regions and slowing overall market growth.

Opportunity:

Rising demand for male aesthetic treatments

The rising demand for male aesthetic treatments are seeking non-invasive cosmetic procedures to enhance their appearance, addressing concerns like aging, hair loss, and body contouring. Mesotherapy's minimally invasive nature and ability to treat issues like wrinkles, fat reduction, and hair thinning align well with male preferences for subtle yet effective treatments. This growing male demographic opens new revenue streams for aesthetic clinics, expanding the market and fuelling the demand for personalized, gender-targeted mesotherapy solutions.

Threat:

Negative public perception and safety concerns

Instances of side effects, such as infections, bruising, or allergic reactions, raise doubts about the safety and effectiveness of mesotherapy. Additionally, the lack of standardized practices and varied formulations across clinics can lead to inconsistent results, further deterring potential clients. Media reports of adverse outcomes or poorly trained practitioners performing the treatment contribute to negative perceptions, making consumers hesitant to undergo mesotherapy, thereby slowing market growth.

Covid-19 Impact

The COVID-19 pandemic had a mixed impact on the mesotherapy market. Initially, elective cosmetic procedures like mesotherapy saw a decline due to lockdowns, clinic closures, and social distancing measures. However, as restrictions eased and telemedicine consultations rose, demand for non-invasive aesthetic treatments rebounded, driven by the "Zoom effect" where people became more conscious of their appearance during virtual meetings. Additionally, rising post-pandemic self-care trends and increased consumer focus on wellness have further supported market recovery.

The amino acids segment is expected to be the largest during the forecast period

Over the estimation period, the amino acids segment is likely to capture the largest market share, due to enhanced treatment efficacy, particularly for skin rejuvenation and anti-aging. Amino acids are essential components in mesotherapy formulations as they help stimulate collagen and elastin production, improving skin elasticity and texture. Their role in cellular repair and regeneration makes them a key ingredient for treating wrinkles, fine lines, and sagging skin. With growing demand for non-invasive, effective aesthetic solutions, amino acid-based mesotherapy treatments have gained popularity, driving market growth as consumers seek improved skin health and vitality.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to specialized infrastructure, skilled medical professionals, and comprehensive care. Hospitals are trusted institutions for cosmetic treatments, making them attractive to patients seeking professional, non-invasive procedures like mesotherapy for skin rejuvenation, anti-aging, and fat reduction. With access to advanced technologies and regulated environments, hospitals ensure better safety and efficacy, boosting patient confidence. Additionally, growing partnerships between hospitals and cosmetic service providers contribute to the increased adoption of mesotherapy, driving market growth through a more extensive patient base.

Region with largest share:

Over the forecast period, the Asia Pacific region is anticipated to hold the largest market share due to rising disposable incomes, increasing awareness of aesthetic procedures, and a growing aging population. Countries like South Korea, Japan, and India are leading in demand for non-invasive cosmetic treatments. The region is witnessing advancements in mesotherapy techniques and products, coupled with a rise in medical tourism for aesthetic procedures. Additionally, the increasing focus on self-care and wellness among consumers further fuels the demand for mesotherapy solutions across the region.

Region with highest CAGR:

During the forecast period, the North America region is anticipated to register the highest CAGR, owing to increased consumer demand for non-invasive aesthetic procedures and rising awareness of skin rejuvenation treatments. The region's aging population seeks effective solutions for anti-aging, fat reduction, and skin tightening. Additionally, advancements in technology and innovative formulations enhance treatment efficacy and safety, attracting more clients. A robust network of skilled practitioners and cosmetic clinics further supports market expansion, while the influence of social media drives interest in aesthetic enhancements across diverse demographics.

Key players in the market

Some of the key players profiled in the Mesotherapy Market include Mesoestetic Pharmaceutical, Revitalash Cosmetics, Inc., MediK8, Filorga Laboratoires, Dusa Pharmaceuticals, Inc., Hyaluronic Acid USA, Suneva Medical, Inc., MesoRex, Revive Light Therapy, Dr. R. F. R. Group, Mesotech, VIVACY Laboratoires, Intraline, Suneva Medical, Allergan (AbbVie Inc.), Merz Pharmaceuticals, Galderma, Croma Pharma GmbH, Aesthetic Solutions and Hugel, Inc.

Key Developments:

In August 2024, Mesoestetic entered into an agreement with a leading distributor in Latin America to enhance the availability of its mesotherapy solutions. This strategic partnership is expected to significantly increase market penetration and brand visibility in this region.

In February 2024, The Company expanded its portfolio through a joint venture with a biotechnology firm focused on developing advanced mesotherapy products. This partnership aims to leverage both companies' expertise to innovate new treatments for skin rejuvenation and anti-aging.

In October 2023, Mesoestetic announced a partnership with a network of aesthetic clinics in North America. This collaboration is expected to facilitate the distribution of its innovative skincare products across the region, enhancing accessibility for consumers seeking advanced aesthetic solutions.

Products Covered:

  • Injectables
  • Devices
  • Other Products

Demographics Covered:

  • Age Group
  • Gender
  • Other Demographics

Ingredients Covered:

  • Homeopathic Remedies
  • Vitamins and Minerals
  • Hyaluronic Acid
  • Amino Acids
  • Plant Extracts
  • Other Ingredients

Distribution Channels Covered:

  • Direct Sales
  • Online Sales
  • Pharmacies
  • Specialty Clinics
  • Other Distribution Channels

Applications Covered:

  • Anti-aging
  • Facial Rejuvenation
  • Stretch Marks
  • Acne & Scar Treatment
  • Fat Loss
  • Hair Loss
  • Other Applications

End Users Covered:

  • Hospitals
  • Dermatology & Cosmetic Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Mesotherapy Market, By Product

  • 5.1 Introduction
  • 5.2 Injectables
    • 5.2.1 Mesotherapy injectables
    • 5.2.2 Needle-free injectables
  • 5.3 Devices
    • 5.3.1 Mesotherapy guns
    • 5.3.2 Electroporation devices
    • 5.3.3 Other delivery systems
  • 5.4 Other Products

6 Global Mesotherapy Market, By Demographic

  • 6.1 Introduction
  • 6.2 Age Group
    • 6.2.1 Adults (18-35 years)
    • 6.2.2 Middle-aged (36-55 years)
    • 6.2.3 Seniors (56 years and above)
  • 6.3 Gender
    • 6.3.1 Male
    • 6.3.2 Female
  • 6.4 Other Demographics

7 Global Mesotherapy Market, By Ingredient

  • 7.1 Introduction
  • 7.2 Homeopathic Remedies
  • 7.3 Vitamins and Minerals
  • 7.4 Hyaluronic Acid
  • 7.5 Amino Acids
  • 7.6 Plant Extracts
  • 7.7 Other Ingredients

8 Global Mesotherapy Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Direct Sales
  • 8.3 Online Sales
  • 8.4 Pharmacies
  • 8.5 Specialty Clinics
  • 8.6 Other Distribution Channels

9 Global Mesotherapy Market, By Application

  • 9.1 Introduction
  • 9.2 Anti-aging
  • 9.3 Facial Rejuvenation
  • 9.4 Stretch Marks
  • 9.5 Acne & Scar Treatment
  • 9.6 Fat Loss
  • 9.7 Hair Loss
  • 9.8 Other Applications

10 Global Mesotherapy Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Dermatology & Cosmetic Clinics
  • 10.4 Other End Users

11 Global Mesotherapy Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Mesoestetic Pharmaceutical
  • 13.2 Revitalash Cosmetics, Inc.
  • 13.3 MediK8
  • 13.4 Filorga Laboratoires
  • 13.5 Dusa Pharmaceuticals, Inc.
  • 13.6 Hyaluronic Acid USA
  • 13.7 Suneva Medical, Inc.
  • 13.8 MesoRex
  • 13.9 Revive Light Therapy
  • 13.10 Dr. R. F. R. Group
  • 13.11 Mesotech
  • 13.12 VIVACY Laboratoires
  • 13.13 Intraline
  • 13.14 Suneva Medical
  • 13.15 Allergan (AbbVie Inc.)
  • 13.16 Merz Pharmaceuticals
  • 13.17 Galderma
  • 13.18 Croma Pharma GmbH
  • 13.19 Aesthetic Solutions
  • 13.20 Hugel, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦